Kristina I. Melkersson, MD
- 3Articles
- 7.2KReads
- 1999–2007Active
- 5Collaborators
About
Kristina I. Melkersson, MD, has authored multiple articles between 1999 and 2007 focusing on schizophrenia and schizoaffective disorders. Her work examines the metabolic effects of antipsychotic medications, including the impact of CYP1A2 and CYP2D6 polymorphisms on drug metabolism and associated insulin and lipid changes in patients treated with clozapine and olanzapine. She has collaborated frequently with researchers such as Anna-Lena Hulting and Kerstin E. Brismar.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
